STRENSIQ
STRENSIQ
Approved
DIN Number
02444607
Drug Class
Human
Market Date
N/A
Company
HC
Alexion Pharma GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02444607
AIG Number0157271001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A16AB13 ASFOTASE ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ASFOTASE ALFAActive
Strength: 40 MG / ML
Monograph: ASFOTASE ALFA